Results 101 to 110 of about 622,843 (190)

Editorial: Emerging and reemerging neglected tropical diseases: their epidemiology, transmission, mitigation, and vaccines and chemotherapeutics advancements, volume II. [PDF]

Front Pharmacol
Mohapatra RK, Mishra S, Kandi V, Mohapatra NP, Sirka CS.   +4 more
europepmc   +1 more source

Optimising superficial parasternal intercostal plane blockade after cardiac surgery: single injection first? [PDF]

Lancet Reg Health Am
Mehta S, Ree RM, Prabhakar C, Sun T, Jen TTH.   +4 more
europepmc   +1 more source

Analysis of Suffix Use for Biosimilar Product Identification in Postmarketing Adverse Event Reporting

Clinical Pharmacology &Therapeutics, EarlyView.
Accurate identification of medicines used in adverse event reports is crucial for effective postmarketing safety surveillance. The US Food and Drug Administration's (FDA) four‐letter suffix naming convention was designed to facilitate accurate biological product identification, but the extent to which these suffixes have been incorporated into ...
Danijela Stojanovic, Lisa Wolf, M. Stacey Ricci, Monica A. Muñoz   +3 more
wiley   +1 more source

Perspectives from the 2024 School on Neuropharmacology Research and Drug Development in Harare, Zimbabwe: insights from participants. [PDF]

Biol Open
Senanu J, Wanyu BY, Burns J, Archibong VB, Chinheya RM, Ombel Musa NS, Zengeni S, Haj-Khlifa A, Adeniji KO, Kolo RM, Caroline M, Sakhri FZ, Chipofya E.   +12 more
europepmc   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Parabrachial neuropeptide Y Y1 receptor-expressing neurons govern the sensory dimension of neuropathic pain. [PDF]

Pain
Allen HN, Nelson TS, Goldstein N, Grabus NK, Brandner A, Hussain F, Gakii NE, Yeung ATM, Kirchner LV, Hilferty D, Betley JN, Khanna R, Taylor BK.   +12 more
europepmc   +1 more source

Effect of third generation beta-adrenoceptor antagonists with vasodilating properties, carveditol and nebivolol, on orthodontic tooth movement in rats

, 2009
Thesis (M.Sc), Department of Pharmacology and Therapeutics, Faculty of Medicine, A.U.
El Asmar, Edward Henri,
core  

Do witnesses of functional/dissociative seizures recall them accurately? A UK experimental study of semiology recall at clinically relevant time points with a pilot intervention

Epilepsia, EarlyView.
Abstract Objective Different causes of transient loss of consciousness (TLOC) carry distinct risks and require different management. Early accurate diagnosis is essential to guide counseling, investigation, and referral. In routine practice, frontline clinicians and specialists often rely on eyewitness accounts, yet the reliability of witness testimony
Adam John Noble, Steven Lane, Amina Al‐Khaddar, Annabelle Blundy, Brenna Dubois, Chloe Pearce, Laszlo Sztriha, Graham Powell, Alistair Wardrope, Rajiv Mohanraj, Anthony Guy Marson, Markus Reuber   +11 more
wiley   +1 more source

CYP2C19 Genotyping to Guide Clopidogrel Prescribing for Neurovascular Indications: A Survey of Institutional Approaches. [PDF]

Clin Pharmacol Ther
Stone RM, Hoffecker G, Schultz A, Davis BH, Bargal SA, Beitelshees AL, El Rouby N, Norris M, Rodriguez KJ, Limdi N, Cavallari LH, Lee CR.   +11 more
europepmc   +1 more source

Epilepsy‐associated SCN2A‐L1342P mutation drives network hyperexcitability and widespread transcriptomic changes in human cortical organoids

Epilepsia, EarlyView.
Abstract Objective SCN2A pathogenic mutations, such as the recurrent heterozygous Nav1.2‐L1342P, are monogenic causes of epilepsy. In this human‐induced pluripotent stem cell–derived model system, we aim to investigate the molecular and cellular mechanisms underlying SCN2A‐L1342P‐associated pathology. Methods Using a human male induced pluripotent stem
Maria I. Olivero‐Acosta, Morgan Robinson, Zhefu Que, Zaiyang Zhang, Karen V. Salazar‐Salazar, Hope Elizabeth Harlow, Vinayak Shankar, Seoyeon Hong, Muhan Wang, Conrad M. Otterbacher, Hina Kadono, Manasi Halurkar, Harish Kothandaraman, Nadia Atallah Lanman, Trang Nguyen, Kyle Wettschurack, Benjamin Zirkle, Layan Yunis, Ningren Cui, Xiaoling Chen, Jingliang Zhang, Jiaxiang Wu, William C. Skarnes, Chongli Yuan, Feng Guo, Megan Abbott, Yang Yang   +26 more
wiley   +1 more source